These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32092394)

  • 1. Left atrial appendage occlusion through a patent foramen ovale: Should we or rather not?
    Tzikas A; Papadopoulos K; Konstantinou D; Ntaios G; Arampatzis C
    Hellenic J Cardiol; 2020; 61(6):442-443. PubMed ID: 32092394
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential uselessness and futility of left atrial appendage occlusion and patent foramen ovale closure in cardioembolic stroke.
    Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2017 Jun; 18(6):393-397. PubMed ID: 28212133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devices to decrease stroke risk.
    Tuzcu EM
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):54S-58S. PubMed ID: 23573575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplatzer left atrial appendage occlusion through a patent foramen ovale.
    Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous percutaneous closure of patent foramen ovale and left atrial appendage].
    Paulo M; García E; Hernández-Antolín RA; Almería C
    Rev Esp Cardiol; 2011 Dec; 64(12):1215-6. PubMed ID: 21601977
    [No Abstract]   [Full Text] [Related]  

  • 7. Leaving no hole unclosed: left atrial appendage occlusion in patients having closure of patent foramen ovale or atrial septal defect.
    Gafoor S; Franke J; Boehm P; Lam S; Bertog S; Vaskelyte L; Hofmann I; Sievert H
    J Interv Cardiol; 2014 Aug; 27(4):414-22. PubMed ID: 25059287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous patent foramen ovale and left atrial appendage closure.
    Versaci F; Saccà S; Mugnolo A; Pacchioni A; Reimers B
    J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):663-4. PubMed ID: 22011553
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent foramen ovale closure for secondary stroke prevention.
    Alkhouli M; Sievert H; Holmes DR
    Eur Heart J; 2019 Jul; 40(28):2339-2350. PubMed ID: 30957864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
    Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
    BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation.
    Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F
    Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
    Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
    [No Abstract]   [Full Text] [Related]  

  • 15. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patent foramen ovale: a harmless fetal remnant that can be a threat in adulthood].
    Eriksson PJ; Jacobsen P
    Lakartidningen; 2011 May 18-24; 108(20):1123-5. PubMed ID: 21815346
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
    Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):555-567. PubMed ID: 28886846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rocking motion of a patent foramen ovale device.
    Savaş G; Yazici S; Dinc Asarcikli L; Terzi S
    Anatol J Cardiol; 2020 Oct; 24(4):E12-E13. PubMed ID: 33001048
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.